Fortune names Lilly among best 100 to work for
For the fifth consecutive year, Eli Lilly says, it has earned the distinction of ranking as one of the 100 Best Companies to Work For in the USA by Fortune magazine. Lilly ranked the highest of four pharmaceutical companies appearing on this year's list.
The seventh annual ranking, appearing in this week's edition of Fortune and at www.fortune.com, is based primarily on employee-opinion surveys researched and compiled by the Great Place to Work Institute. Some 46,526 randomly-selected employees from 304 candidate companies completed a survey that measures the level of credibility, respect, fairness, pride and camaraderie in the workplace. Each candidate company also filled out a questionnaire detailing its people policies, practices and philosophies.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze